Arch Therapeutics Announces May 26, 2016 $3.4 Million Private Placement

FRAMINGHAM, MA ARTH, (Marketwired May 27, 2016) Arch Therapeutics, Inc. (OTCQB: ARTH) ( Arch or the Company ), developer of the AC5 Surgical Hemostatic Device™ (AC5™) for use in controlling bleeding and fluid loss in order to provide faster and safer surgical and interventional care, is pleased to announce that it has entered into subscription agreements with a group of accredited investors (the Investors ) to purchase approximately $3.4 million of the Company s securities in a private placement pursuant to Section The post Arch Therapeutics Announces May 26, 2016 $3.4 Million Private Placement appeared first on Public Wire.
http://bit.ly/1NSoDel

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: